Skip to content
Wenlo
Sign in
← Markets

IDEXX Laboratories, Inc.

Sharon E. Underberg (EVP, GC & Corporate Secretary) sells IDXX shares

4IDXXFiled Nov 5, 2026, 5:02 PM ET· Period Nov 4, 2026

AI-generated summary

Sharon E. Underberg, EVP, GC & Corporate Secretary, exercised options for 8,906 shares of Common Stock valued at $2,571,874.68 and sold 8,906 shares of Common Stock for $6,132,604.99 at an average price of $688.59. After these transactions, the insider directly held 7,168.654 shares of Common Stock.

Key facts

Insider
Sharon E. Underberg · EVP, GC & Corporate Secretary
DateTransactionSharesPriceValueHeld afterOwnership
Nov 4, 2026M · exercise or conversion of a derivativeFootnotes F1+8,906$288.78$2,571,874.6816,074.654Direct
Nov 4, 2026S · open-market saleFootnotes F2−6,348$688.25$4,368,995.139,726.654Direct
Nov 4, 2026S · open-market saleFootnotes F3−1,503$689.05$1,035,636.448,223.654Direct
Nov 4, 2026S · open-market saleFootnotes F4−1,055$690.02$727,973.427,168.654Direct
Nov 4, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right-to-buy)Footnotes F6, F5−8,906——0Direct
Footnotes
  1. F1 Includes a total of 31 shares acquired under the Issuer's Employee Stock Purchase Plan on March 31, 2026, June 30, 2026 and September 30, 2026.
  2. F2 Represents the weighted average price of the shares sold ranging from a low of $687.70 to a high of $688.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  3. F3 Represents the weighted average price of the shares sold ranging from a low of $688.70 to a high of $689.56 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  4. F4 Represents the weighted average price of the shares sold ranging from a low of $690.02 to a high of $690.04 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  5. F5 Grant of option to buy shares of Issuer common stock that vested in four annual installments beginning February 14, 2021.
  6. F6 Not applicable.

More IDXX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.